Effect of adding midazolam to bupivacaine during ultrasound guided single injection rectus sheath block.

Effect of adding midazolam to bupivacaine during ultrasound guided single injection rectus sheath block. A randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201612001905316

Enrollment

Registered

2016-12-03

Start date

2016-12-12

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

midazolam group

control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients ASA I or II undergoing umbilical hernia repair

Exclusion criteria

Exclusion criteria: refusal of the patients to give informed consent, pre-existing coagulation disorders (international normalized ratio > 1.5), morbid obesity (body mass index ¿ 35 kg/m2), significant cardiac, hepatic or renal disease, local infection at the site of the block or allergy to the drug under study

Design outcomes

Primary

Measure	Time frame
postoperative 48 h morphine consumption	—

Secondary

Measure	Time frame
duration of analgesia, postoperative pain, as evaluated by VAS for pain scoring at 1, 2,6, 12, 24, and 48 h postoperatively, reported nausea, vomiting, somnolence or any adverse drug reactions like pruritus, and bowel activity	—

Countries

Egypt

Contacts

Public Contactkhaled mahmoud

Professor in anesthesiology, Minoufiya faculty of medicine

mahmoudk16@yahoo.com+201224884620

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026